製品名:Cyclopropanecarboxylic acid, 2-methyl-, (1S,2S)-

IUPAC Name:(1S,2S)-2-methylcyclopropane-1-carboxylic acid

CAS番号:14590-52-4
分子式:C5H8O2
純度:95%+
カタログ番号:CM464067
分子量:100.12

包装単位 有効在庫 価格(USD) 数量
CM464067-100mg in stock Ɛȅǫ
CM464067-250mg in stock ȅƚƚ
CM464067-10g in stock ȅƚƚƚ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:14590-52-4
分子式:C5H8O2
融点:-
SMILESコード:C[C@H]1C[C@@H]1C(O)=O
密度:
カタログ番号:CM464067
分子量:100.12
沸点:
MDL番号:MFCD19228287
保管方法:

Category Infos

Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.

Column Infos

RMC-6236
Over 30% of all human cancers, including a certain percentage of pancreatic, colorectal, lung cancers, and AML are driven by mutations of RAS genes. There is a significant unmet medical need in RAS mutant cancers.
Revolution Medicines’ investigational drug, RMC-6236 is an oral, non-covalent, RAS (ON) inhibitor that is selective for the active, GTP-bound state of both mutant and wild-type variants of the canonical RAS isoforms. RMC-6236 is under clinical phase I studies as monotherapy in NSCLC and PDAC, and advanced solid tumors harboring KRAS G12X mutations.

Related Products